TAHO Pharmaceuticals Ltd.
3:00 PM - 3:15 PM (EDT), Tuesday, June 6, 2023 ・ Session Room 104C
TAHO is a commercial-stage specialty pharma pioneering in oral, transdermal drug delivery systems.
Collaborating with our partners across three continents, our pipeline of medicines targets CNS, Geriatric, and Pediatric therapies that provide caregivers with significant treatment options. From concept to commercial, we have several products launched in major markets. Trusted by partner pharma, we devote toward partner value and innovation.
Collaborating with our partners across three continents, our pipeline of medicines targets CNS, Geriatric, and Pediatric therapies that provide caregivers with significant treatment options. From concept to commercial, we have several products launched in major markets. Trusted by partner pharma, we devote toward partner value and innovation.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Taiwan
Year Founded:
2010
Main Therapeutic Focus:
Cardiovascular
Lead Product in Development:
apixaban oral film
Development Phase of Primary Product:
Phase I
Number Of Unlicensed Products (For Which You Are Seeking Partners):
7
Speaker
